P53 accumulation, deoxyribonucleic acid ploidy and progression of bladder cancer

Journal of Urology

Volumn 157, Issue 4, 1997, Pages 1250-1253

  Raitanen, Mika P ^a   Tammela, Teuvo L J ^a   Kallioinen, Matti ^a   Isola, Jorma ^a  

^a NONE

Author keywords

bladder neoplasms; DNA ploidy; neoplasm metastasis; protein p53

Indexed keywords

DNA; PROTEIN P53;

ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; DISEASE COURSE; GENE EXPRESSION; GENETIC MARKER; HUMAN; HUMAN TISSUE; METASTASIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0030997142     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64939-5     Document Type: Article

References (22)

1. Torti, F. M. and Lum, B. L.: Superficial bladder cancer. Risk of recurrence and potential role for interferon therapy. Cancer, 59: 613, 1987.
2. Kiemeney, L. A. L. M., Witjes, J. A., Heijbroek, R. P., Verbeek, A.L.M. and Debruyne, F.M.J.: Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J. Urol., 150: 60, 1993.
3. Heney, N. M., Ahmed, S., Flanagan, M. J., Frable, W., Corder, M. P., Hafermann, M. D. and Hawkins, I. R. for National Bladder Cancer Collaborative Group A: Superficial bladder cancer: progression and recurrence. J. Urol., 130: 1083, 1983.
4. Lipponen, P. K., Eskelinen, M. J., Kiviranta, J. and Nordling, S.: Classic prognostic factors, flow cytometric data, nuclear morphometric variables and mitotic indexes as predictors in transitional cell bladder cancer. Anticancer Res., 11: 911, 1991.
5. Lipponen, P. K., Eskelinen, M. J. and Nordling, S.: Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy. Eur. J. Cancer, 27: 877, 1991.
6. Wright, C., Mellon, K., Johnston, P., Lane, D. P., Harris, A. L., Horne, C. H. and Neal, D. E.: Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Brit. J. Urol., 63: 967, 1991.
7. Esrig, D., Spruck, C. H., III, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A. and Cote, R.J.: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Amer. J. Path., 143: 1389, 1993.
8. Esrig, D., Elmajian, D., Groshen, S., Freeman, J.A., Stein, J. P., Chen, S. C., Nichols, P. W., Skinner, D. G., Jones, P. A. and Cote, R. J.: Accumulation of nuclear p53 and tumor progression in bladder cancer. New Engl. J. Med., 331: 1259, 1994.
9. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C.: p53 mutations in human cancers. Science, 253: 49, 1991.
10. TNM Classification of Malignant Tumours, 4th ed. Edited by P. Hermanek and L. H. Sobin. New York: Springer-Verlag. International Union Against Cancer, 1987.
11. Mostofi, F. K.: Histological typing of urinary bladder tumours. In: International Histological Classification of Tumours. Geneva: World Health Organization, 1973.
12. Kallioniemi, O. P., Visakorpi, T., Holli, K., Heikkinen, A., Isola, J. and Koivula, T.: Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing. Cytometry, 12: 413, 1991.
13. Lane, D. P.: Cancer: p53, guardian of the genome. Nature, 358: 15, 1992.
14. Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R. and Frost, P.: Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252: 706, 1991.
15. Sarkis, A. S., Dalbagni, G., Cordon-Cardo, C., Melamed, J., Zhang, Z.-F., Sheinfeld, J., Fair, W., Herr, H. W. and Reuter, V.E.: Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol., 152: 388, 1994.
16. Uchida, T., Wada, C., Ishida, H., Wang, C., Egawa, S., Yokoyama, E., Kameya, T. and Koshiba, K.: p53 mutations and prognosis in bladder tumors. J. Urol., 153: 1097, 1995.
17. Ye, D. W., Zheng, J. F., Qian, S. X. and Ma, Y. J.: Expression of p53 product in Chinese human bladder carcinoma. Urol. Res., 21: 223, 1993.
18. Soini, Y., Turpeenniemi-Hujanen, T., Kamel, D., Autio-Harmainen, H., Risteli, J., Risteli, L., Nuorva, K., Pääkkö, P. and Vähäkangas K.: p53 immunohistochemistry in transitional cell carcinoma and dysplasia of the urinary bladder correlates with disease progression. Brit. J. Cancer, 68: 1029, 1993.
19. Blomjous, E. C., Schipper, N. W., Baak, J. P., Vos, W., De Voogt, H. J. and Meijer, C.J.: The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Amer. J. Clin. Path., 91: 243, 1989.
20. Sanchez-Fernandez de Sevilla, M. C., Gil-Salom, M., Perez-Baceta, M., Morell-Quadreny, L., Martinez-Diaz, F., Iborra-Juan, I., Fenollosa-Entrena, B. and Llombart-Bosch, A.: DNA-ploidy, morphometric-stereological and P-glycoprotein study of superficial bladder carcinomas. Eur. Urol., suppl. 1, 21: 16, 1992.
21. Lipponen, P. K.: Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int. J. Cancer, 53: 365, 1993.
22. Mellon, K., Wilkinson, S., Vickers, J., Robinson, M. C., Shenton, B. K. and Neal, D. E.: Abnormalities in p53 and DNA content in transitional cell carcinoma of the bladder. Brit. J. Urol., 73: 522, 1994.